新型热响应性凝胶作为脂氧素递送系统的潜力
本研究评估了基于聚异氰肽(PIC)的新型热响应性水凝胶作为牙周局部给药注射载体的性能。制备了0.2%、0.5%和1% w/w的PIC凝胶,以20%和26% w/w的泊洛沙姆407(P407)凝胶为对照,负载脂氧素A4(LXA4)。结果显示PIC凝胶在磷酸盐缓冲液中至少保持凝胶完整性2周,而P407凝胶在1周内完全崩解;LXA4释放呈初始突释后持续约4天,突释程度与聚合物浓度负相关,且释放后仍保持生物活性;1% PIC凝胶无细胞毒性,但26% P407抑制牙周膜细胞和牙龈上皮细胞生长。结论认为PIC凝胶是牙周药物递送的潜在候选者。
要点
- PIC凝胶在PBS中至少2周保持完整,P407凝胶1周内崩解。
- LXA4从1% PIC或26% P407凝胶中释放呈突释后持续约4天。
- 1% PIC凝胶无细胞毒性,26% P407抑制牙周细胞生长。
核心结论
- 热响应性PIC凝胶是牙周药物递送的潜在候选者。
研究设计与样本
- 制备0.2%、0.5%、1% w/w的PIC凝胶,以20%和26% w/w的P407凝胶为对照,负载LXA4。
- 评价动态力学性能、可注射性与稳定性、LXA4释放与生物活性及细胞相容性。
主要发现
- PIC和P407凝胶的凝胶化温度约为13°C至23°C。
- PIC凝胶因聚合物浓度低,黏度和机械强度低于P407凝胶。
- PIC凝胶在磷酸盐缓冲液中至少2周保持凝胶完整性,P407凝胶1周内完全崩解。
- LXA4在中性和碱性介质中化学稳定超过1个月。
- LXA4从1% PIC或26% P407凝胶中释放呈初始突释后持续释放约4天,突释程度与聚合物浓度负相关。
临床怎么用
- PIC凝胶因长效稳定和低细胞毒性,可能适合牙周局部给药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this study was to evaluate a novel thermoresponsive polyisocyanopeptide (PIC)-based hydrogel as an injectable carrier for local drug delivery for periodontal applications. Three formulations of PIC gels, 0.2%, 0.5%, and 1% w/w, were prepared. As controls, commercially available poloxamer 407 (P407) gels of 20% and 26% w/w were used. Lipoxin A4 (LXA4), a proresolving drug, was suspended into the gel solutions. The systems were evaluated regarding dynamic mechanical properties, injectability and stability, release and bioactivity of LXA4, and cytocompatibility. Results showed that the gelation temperatures of PIC and P407 gels were around 13°C to 23°C. PIC gels were less viscous and mechanically weaker than P407 gels due to the low polymer concentrations. However, PIC gels kept gel integrity for at least 2 wk when incubated with phosphate-buffered saline, whereas P407 gels were disintegrated totally within 1 wk. LXA4 was chemically stable in both neutral and alkaline medium for over 1 mo. The release of LXA4 from either 1% PIC or 26% P407 gels depicted an initial burst release followed by a sustained release for around 4 d. The extent of burst release was negatively correlated to the polymer concentration. LXA4 remained bioactive after release from PIC gels. No cytotoxicity was observed for 1% PIC gel. However, 26% P407 inhibited periodontal ligament cell and gingival epithelial cell growth. In conclusion, the thermoresponsive PIC gel is a potential candidate for periodontal drug delivery.
引用
- Wang B, Shao J, Jansen JA, et al. A Novel Thermoresponsive Gel as a Potential Delivery System for Lipoxin. J Dent Res. 2018. PMID: 30403904. doi:10.1177/0022034518810213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。